97 related articles for article (PubMed ID: 19369962)
1. Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity.
Kern W; Haferlach C; Bacher U; Haferlach T; Schnittger S
Leukemia; 2009 Jul; 23(7):1361-4. PubMed ID: 19369962
[No Abstract] [Full Text] [Related]
2. Reply to: 'Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity' by Kern et al.
Oelschlaegel U; Mohr B; Schaich M; Kroschinsky F; Parmentier S; Bornhäuser M; Ehninger G; Thiede C
Leukemia; 2011 May; 25(5):895-7. PubMed ID: 21331074
[No Abstract] [Full Text] [Related]
3. Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia.
Oelschlaegel U; Koch S; Mohr B; Schaich M; Falini B; Ehninger G; Thiede C
Leukemia; 2010 Oct; 24(10):1813-6. PubMed ID: 20724983
[No Abstract] [Full Text] [Related]
4. Is the association of "cup-like" nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful?
Bennett JM; Pryor J; Laughlin TS; Rothberg PG; Burack WR
Am J Clin Pathol; 2010 Oct; 134(4):648-52. PubMed ID: 20855646
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related acute myeloid leukaemia with mutated NPM1: treatment induced or de novo in origin?
Falini B
Leukemia; 2008 May; 22(5):891-2. PubMed ID: 18478020
[No Abstract] [Full Text] [Related]
7. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
9. Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
Mori Y; Yoshimoto G; Kumano T; Miyamoto T; Iino T; Takenaka K; Iwasaki H; Harada N; Kinukawa N; Nagafuji K; Teshima T; Shimoda K; Akashi K; Harada M
Eur J Haematol; 2007 Jul; 79(1):17-24. PubMed ID: 17598835
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
[TBL] [Abstract][Full Text] [Related]
11. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
[TBL] [Abstract][Full Text] [Related]
12. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
Bains A; Luthra R; Medeiros LJ; Zuo Z
Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125
[TBL] [Abstract][Full Text] [Related]
13. Two novel NPM1 mutations in an acute myeloid leukemia patient transformed from primary myelofibrosis.
Park SH; Chi HS; Shim H; Jang S; Park CJ
Int J Lab Hematol; 2013 Feb; 35(1):e1-3. PubMed ID: 22978565
[No Abstract] [Full Text] [Related]
14. Donor lymphocyte infusion induces polyspecific CD8(+) T-cell responses with concurrent molecular remission in acute myeloid leukemia with NPM1 mutation.
Hofmann S; Götz M; Schneider V; Guillaume P; Bunjes D; Döhner H; Wiesneth M; Greiner J
J Clin Oncol; 2013 Jan; 31(3):e44-7. PubMed ID: 23248243
[No Abstract] [Full Text] [Related]
15. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
Krönke J; Schlenk RF; Jensen KO; Tschürtz F; Corbacioglu A; Gaidzik VI; Paschka P; Onken S; Eiwen K; Habdank M; Späth D; Lübbert M; Wattad M; Kindler T; Salih HR; Held G; Nachbaur D; von Lilienfeld-Toal M; Germing U; Haase D; Mergenthaler HG; Krauter J; Ganser A; Göhring G; Schlegelberger B; Döhner H; Döhner K
J Clin Oncol; 2011 Jul; 29(19):2709-16. PubMed ID: 21555683
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
18. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
Zhang Y; Zhang M; Yang L; Xiao Z
Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
[TBL] [Abstract][Full Text] [Related]
19. Reversal of FLT3 mutational status and sustained expression of NPM1 mutation in paired presentation, and relapse samples in a patient with acute myeloid leukemia.
Radojkovic M; Tosic N; Colovic N; Ristic S; Pavlovic S; Colovic M
Ann Clin Lab Sci; 2012; 42(2):186-90. PubMed ID: 22585616
[TBL] [Abstract][Full Text] [Related]
20. Sustained expression of nucleophosmin (NPM1) mutation at late relapse presenting as isolated myeloid sarcoma in a patient with acute myeloid leukemia.
Scholl S; Lüftner J; Mügge LO; Schmidt V; Fricke HJ; Höffken K
Ann Hematol; 2007 Oct; 86(10):763-5. PubMed ID: 17639390
[No Abstract] [Full Text] [Related]
[Next] [New Search]